Clinical trial

Azilsartan in Patients With Diabetic Kidney Disease and Hypertension

NCT05753696

Study summary

ClinicalTrials.gov

Azilsartan in Patients With Diabetic Kidney Disease and Hypertension

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Azilsartan Normalized identity: azilsartan View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Losartan Normalized identity: losartan View linked drug · Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-04-01

PhaseNA

Conditions

Proteinuriaverified · MONDO: proteinuria

Kidney Dysfunctionunresolved

Blood Pressureunresolved

Diabetic Kidney Diseaseverified · MONDO: diabetic kidney disease

Interventions

AzilsartanDRUG · verified · RxNorm: azilsartan

LosartanDRUG · verified · RxNorm: losartan

Sponsors & collaborators

Second Affiliated Hospital, Zhejiang University, School of Medicinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05753696 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.